188 related articles for article (PubMed ID: 30825976)
1. MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.
van den Ende RPJ; Rigter LS; Kerkhof EM; van Persijn van Meerten EL; Rijkmans EC; Lambregts DMJ; van Triest B; van Leerdam ME; Staring M; Marijnen CAM; van der Heide UA
Radiother Oncol; 2019 Mar; 132():93-99. PubMed ID: 30825976
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer.
van den Ende RPJ; Kerkhof EM; Rigter LS; van Leerdam ME; Peters FP; van Triest B; Staring M; Marijnen CAM; van der Heide UA
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1151-1159. PubMed ID: 31476419
[TBL] [Abstract][Full Text] [Related]
3. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
[TBL] [Abstract][Full Text] [Related]
4. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
[TBL] [Abstract][Full Text] [Related]
5. End-to-end validation of fiducial tracking accuracy in robotic radiosurgery using MRI-only simulation imaging.
Singhrao K; Zubair M; Nano T; Scholey JE; Descovich M
Med Phys; 2024 Jan; 51(1):31-41. PubMed ID: 38055419
[TBL] [Abstract][Full Text] [Related]
6. Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.
Tanaka O; Komeda H; Hirose S; Taniguchi T; Ono K; Matsuo M
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e405-e411. PubMed ID: 29193796
[TBL] [Abstract][Full Text] [Related]
7. Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data.
Wegener D; Zips D; Thorwarth D; Weiß J; Othman AE; Grosse U; Notohamiprodjo M; Nikolaou K; Müller AC
Acta Oncol; 2019 Jan; 58(1):88-94. PubMed ID: 30264629
[TBL] [Abstract][Full Text] [Related]
8. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
[TBL] [Abstract][Full Text] [Related]
9. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
[TBL] [Abstract][Full Text] [Related]
10. EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types.
Rigter LS; Rijkmans EC; Inderson A; van den Ende RPJ; Kerkhof EM; Ketelaars M; van Dieren J; Veenendaal RA; van Triest B; Marijnen CAM; van der Heide UA; van Leerdam ME
Endosc Int Open; 2019 Nov; 7(11):E1357-E1364. PubMed ID: 31673605
[No Abstract] [Full Text] [Related]
11. Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers.
Be KH; Khor R; Lim Joon D; Starvaggi B; Chao M; Ng SP; Ng M; Zorron Cheng Tao Pu L; Efthymiou M; Vaughan R; Chandran S
World J Gastroenterol; 2021 Nov; 27(42):7387-7401. PubMed ID: 34876797
[TBL] [Abstract][Full Text] [Related]
12. Qualitative evaluation of fiducial markers for radiotherapy imaging.
Chan MF; Cohen GN; Deasy JO
Technol Cancer Res Treat; 2015 Jun; 14(3):298-304. PubMed ID: 25230715
[TBL] [Abstract][Full Text] [Related]
13. Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom.
Schneider S; Jølck RI; Troost EGC; Hoffmann AL
Med Phys; 2018 Jan; 45(1):37-47. PubMed ID: 29136287
[TBL] [Abstract][Full Text] [Related]
14. Potential position errors using fiducial markers for gated image guided radiotherapy.
Nielsen MS; Nyström MW; Carl J
Acta Oncol; 2013 Oct; 52(7):1472-6. PubMed ID: 23984813
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
[TBL] [Abstract][Full Text] [Related]
16. Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
Jonsson JH; Garpebring A; Karlsson MG; Nyholm T
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1612-8. PubMed ID: 21477942
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
[TBL] [Abstract][Full Text] [Related]
18. [Intraprostatic fiducials in stereotactic radiotherapy for prostate cancer].
Cordoba A; Pasquier D; Nickers P; Lacornerie T; Lartigau É
Cancer Radiother; 2016 Dec; 20(8):815-819. PubMed ID: 27793529
[TBL] [Abstract][Full Text] [Related]
19. Developing a MLC modifier program to improve fiducial detection for MV/kV imaging during hypofractionated prostate volumetric modulated arc therapy.
Happersett L; Wang P; Zhang P; Mechalakos J; Li G; Eley E; Zelefsky M; Mageras G; Damato AL; Hunt M
J Appl Clin Med Phys; 2019 Jun; 20(6):120-124. PubMed ID: 31116478
[TBL] [Abstract][Full Text] [Related]
20. Performance of a new preloaded fiducial needle to guide radiation therapy of upper gastrointestinal cancers.
Phan VA; Dalfsen R; Le H; Nguyen NQ
Endoscopy; 2019 May; 51(5):463-467. PubMed ID: 30577061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
